Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Industry Pharmaceutical AstraZeneca harnessed a select group of Scientists within Client AstraZeneca Neuroscience division headquartered in Boston, Mass. Once Project Vendor Selection – Clinical Data Management the parent company to form a small yet effective called AstraZeneca Neuroscience, now Neuroscience iMed (short for innovative Medicines), the division currently manages an entire portfolio of Central Nervous System and pain programs from target identification through Phase II proof of concept studies. Because of the complex Duration Six month challenges of developing successful neurological drugs, the parent company wanted a focused division to increase the probability of successful drug launches while minimizing investment dollars. Their goal was to outsource nearly every support activity so the team could dedicate their efforts to research and analysis to make informed decisions about drug discovery and development. Utilizing our vendor selection methodology, Cogitas Consulting was hired to lead the effort to select a clinical trial management system (CTMS). Initially, we assembled an evaluation team that had a clear understanding of the business requirements. We interviewed the stakeholders and users, gathered technical information including standards and descriptions of current technical environments to help formulate a Request for Proposal (RFP) document. 1 Vendor Selection – AstraZeneca| Cogitas Consulting After the evaluation team published the requirements document, we compiled a list of qualified vendors. Neuroscience wanted a vendor with extensive experience in the pharmaceutical industry and that had a clear understanding of regulatory environments. Offering Software as a Service (SaaS) solution was an additional requirement. A short list was created and the RFP disseminated. An evaluation matrix was created after reviewing the responses. Three vendors were asked back to perform demonstrations using use cases decided on by the team. MaxisIT was selected for their end-to-end clinical research and development technology platform, which includes data warehousing as well as analytics, specifically for Pharmaceutical and Life Science clients. Cogitas managed the client references verification process as well as the contract development to help complete the engagement. We were requested to remain in the lead position to manage the implementation portion of the project, which went smoothly with our oversight. The engagement implemented technologies and tools needed to turn data into information, information into knowledge, and knowledge into plans that drive profitable business action. Today, Neuroscience iMed has partnered with over fifteen academia, industry and foundation firms that share information to advance the innovative programs that make up AstraZeneca’s Neuroscience pipeline for medication addressing Alzheimer’s, Parkinson’s, autism, schizophrenia, drug addiction, and Amyotrophic lateral sclerosis (ALS). 2 Vendor Selection – AstraZeneca| Cogitas Consulting